Characterization of Protein Tyrosine Kinases from Human Breast Cancer: Involvement of the c-src Oncogene Product

Cancer Research

Volumn 52, Issue 17, 1992, Pages 4773-4778

  Staal, G E J ^a,c   Rijksen, G ^a   van Beurden, E A C M ^a   Michels, A A ^a  

^a Division of Medical Oncology   (Netherlands)

^b Department of Surgery ^*  (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PROTEIN TYROSINE KINASE;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; FAST PROTEIN LIQUID CHROMATOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; LYMPHOCYTE; ONCOGENE; PRIORITY JOURNAL;

BLOTTING, WESTERN; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMAN; LYMPHOCYTES; PRECIPITIN TESTS; PROTEIN-TYROSINE KINASE; PROTO-ONCOGENE PROTEIN PP60(C-SRC); SUPPORT, NON-U.S. GOV'T;

EID: 0026674221     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
2. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Uvin, W. J., Stuart, S. G., Udove, J., Ullrich, A., and Press, M. F. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.
3. Ali, I. U., Campbell, G., Lidereau, R., and Callahan, R. Lack of evidence for the prognostic significance of c-erbB-1 amplification in human breast carcinoma. Oncol. Res., i: 139-146, 1988.
4. Ali, I. U., Campbell, G., Lidereau, R., and Callahan, R. Amplification of c-erbB-2 and aggressive human breast tumors? Science (Washington DC), 240: 1795-1796, 1988.
5. Van de Vijver, M. J., Van de Bersselaar, R., Devilee, P., Cornelisse, C., Peterse, J., and Nusse, R. Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol. Cell. Biol., 7: 2019-2023, 1987.
6. Escot, C., Theillet, C., Lidereau, R., Spyratos, F., Champeme, M-H., Gest, J., and Callahan, R. Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc. Natl. Acad. Sci. USA, 83: 4834-4838, 1986.
7. Guerin, M., Barrois, M., Terrier, M. J., Spielmann, M., and Riou, G. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncol. Res., i; 21-31, 1988.
8. Lidereau, R., Callahan, R., Dickson, C., Peters, G., Escot, C., and Ali, L U. Amplification of the int-2 gene in primary human breast tumors. Oncol. Res., 2: 285-291, 1988.
9. Singletary, S. E., Baker, F. L., Spitzer, G., Tucker, S. L., Tomasovic, B., Brock, W. A., Ajani, J. A., and Kelly, A. M. Biological effect of epidermal growth factor on the in vitro growth of human tumors. Cancer Res., 47: 403-406, 1987.
10. Sainsbury, J. R. C., Sherbet, G. V., Famdon, J. R., and Harris, A. L. Epidermal growth factor receptors and oestrogen receptors in human breast cancer. Lancet, 2: 364-366, 1985.
11. Hunter, T., and Cooper, J. A. Protein-tyrosine kinases. Annu. Rev. Biochem., 54: 897-930, 1985.
12. Ullrich, A., and Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 61: 203-212, 1990.
13. Druker, B. J., Mamon, H. J., and Roberts, T. M. Oncogenes, growth factors, and signal transduction. N. Engl. J. Med., 321: 1383-1391, 1989.
14. Heldin, C-H., and Westermark, B. Growth factors as transforming proteins. Eur. J. Biochem., 184:487-496, 1989.
15. Hennipman, A., van Oirschot, B. A., Smits, J., Rijksen, G., and Staal, G. E. J. Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. Cancer Res., 49: 516-521, 1989.
16. De Boer, M., and Roos, D. Metabolic comparison between basophils and other leukocytes from human blood. J. Immunol., 136: 3447-3454, 1986.
17. Rijksen, G., van Oirschot, B. A., and Staal, G. E. J. Nonradioactive assays of protein-tyrosine kinase activity using anti-phosphotyrosine antibodies. Methods Enzymol., 200: 98-107, 1991.
18. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
19. Lazaro, L., Gonzalez, M., Roy, G., Villar, L. M., and Gonzalez-Porque, P. Description of an enzyme-linked immunosorbent assay for the detection of protein tyrosine kinase. Anal. Biochem., 192: 257-261, 1991.
20. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
21. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227:680-685, 1970.
22. Lipsich, L. A., Lewis, A. J., and Brugge, J. S. Isolation of Monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses. J. Virol., 48: 352-360, 1983.
23. Huang, M-M., Bolen, J. B., Barnwell, J. W., Shattil, S. J., and Brugge, J. S. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc. Natl. Acad. Sci. USA, 88: 7844-7848, 1991.
24. Courtneidge, S. A., Levinson, A. D., and Bishop, J. M. The protein encoded by the transforming gene of avian sarcoma virus (pp60c-src) and a homologous protein in normal cells (pp60c-src) are associated with the plasma membrane. Proc. Natl. Acad. Sci. USA, 77: 3783-3787, 1980.
25. Krueger, J. G., Wang, E., and Goldberg, A. R. Evidence that the src gene product of Rous sarcoma virus is membrane associated. Virology, 101: 25-40, 1980.
26. Pellman, D., Garber, E. A., Cross, F. R., and Hanafusa, H. Fine structural mapping of a critical NH2-terminal region of p60c-src. Proc. Natl. Acad. Sci. USA, 82: 1623-1627, 1985.
27. Buss, J. E., Kamps, M. P., and Sefton, B. M. Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein. Mol. Cell. Biol., 4: 2697-2704, 1984.
28. Wilcox, C., Hu, J-S., and Olson, E. N. Acylation of proteins with myristic acid occurs cotranslationally. Science (Washington DC), 238: 1275-1278, 1987.
29. Morgan, D. O., Kaplan, J. M., Bishop, J. M., and Varmus, H. E. Mitosis-specific phosphorylation of p60c-src by p34cdc2-associated protein kinase. Cell, 57: 775-786, 1989.
30. Sefton, B. M. The Ick tyrosine protein kinase. Oncogene, 6:683-686,1991.
31. Srivastava, A. K., Chiasson, J-C., Chiasson, J-L., Lacroix, A., and Windsich, L. Biochemical characteristics of cytosolic and particulate forms of protein tyrosine kinases from Mmethyl-N-nitrosurea (MNU)-induced rat mammary carcinoma. Mol. Cell. Biochem., 106: 87-97, 1991.
32. Rosen, N., Bolen, J. B., Schwartz, A. M., Cohen, P., DeSeau, V., and Israel, M. A. Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. J. Biol. Chem., 261: 13754-13759, 1986.
33. Cartwright, C. A., Meisler, A. I., and Eckhart, W. Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. Proc. Natl. Acad. Sci. USA, 87: 558-562, 1990.
34. Bolen, J. B., Veillette, A., Schwartz, A. M., DeSeau, V., and Rosen, N. Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc. Natl. Acad. Sci. USA, 84: 2251-2255, 1987.
35. Cartwright, C. A., Kamps, M. P., Meisler, A. I., Pipas, J. M., and Eckhart, W. pp60c-src” activation in human colon carcinoma. J. Clin. Invest., 83:2025-2033, 1989.
36. Wang, P., Fromowitz, F., Koslow, M., Hagag, N., Johnson, B., and Viola, M. c-jir structure in human cancers with elevated pp60' “*' activity. Br. J. Cancer, 64: 531-533, 1991.
37. Kmiecik, T. E., Johnson, P. J., and Shalloway, D. Regulation by the autophosphorylation site in overexpressed pp60c-src. Mol. Cell. Biol., 8: 4541-4546, 1988.
38. Harvey, R., Hehir, K. M., Smith, A. E., and Cheng, S. H. pp60c-src' Variants containing lesions that affect phosphorylation at tyrosines 416 and 527. Mol. Cell. Biol., 9: 3647-3656, 1989.
39. Abraham, N., and Veillette, A. Activation of p56/cAc through mutation of a regulatory carboxy-terminal tyrosine residue requires intact sites of autophosphorylation and myristylation. Mol. Cell. Biol., 10: 5197-5206, 1990.
40. Espino, P. C., Harvey, R., Schweickhardt, R. L., White, G. A., Smith, A. E., and Cheng, S. H. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation. Oncogene, 5: 283-293, 1990.
41. Hirai, H., and Varmus, H. E. Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src. Mol. Cell. Biol., 10: 1307-1318, 1990.
42. O'Brien, M. C., Fukui, Y., and Hanafusa, H. Activation of the proto-oncogene p60c-src by point mutations in the SH2 domain. Mol. Cell. Biol., 10: 2855-2862, 1990.
43. Takeya, T., and Hanafusa, H. Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus. Cell, 32:881-890, 1983.
44. Jove, R., and Hanafusa, H. Cell transformation by the viral src oncogene. Annu. Rev. Cell Biol., 3: 31-56, 1987.
45. Veillette, A., Bookman, M. A., Horak, E. M., Samelson, L. E., and Bolen, J. B. Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p561ck. Nature (Lond.), 338: 257-259, 1989.